Volvalerelactone A

Details

Top
Internal ID d20a8286-6e76-4695-be37-af3b839af306
Taxonomy Organoheterocyclic compounds > Lactones > Delta valerolactones
IUPAC Name (1S,2R,3S,5S,8S)-4,4,8-trimethyl-10-oxo-9-oxatricyclo[6.4.0.03,5]dodecane-2-carboxylic acid
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C15H22O4/c1-14(2)9-6-7-15(3)8(4-5-10(16)19-15)11(12(9)14)13(17)18/h8-9,11-12H,4-7H2,1-3H3,(H,17,18)/t8-,9-,11-,12-,15-/m0/s1
InChI Key AFMMLDAVYSFRHS-HGNGLJKMSA-N
Popularity 3 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H22O4
Molecular Weight 266.33 g/mol
Exact Mass 266.15180918 g/mol
Topological Polar Surface Area (TPSA) 63.60 Ų
XlogP 2.20
Atomic LogP (AlogP) 2.47
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Volvalerelactone A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9219 92.19%
Caco-2 + 0.7450 74.50%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability - 0.5143 51.43%
Subcellular localzation Mitochondria 0.7410 74.10%
OATP2B1 inhibitior - 0.8460 84.60%
OATP1B1 inhibitior + 0.8862 88.62%
OATP1B3 inhibitior + 0.9635 96.35%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.7000 70.00%
BSEP inhibitior - 0.7587 75.87%
P-glycoprotein inhibitior - 0.8269 82.69%
P-glycoprotein substrate - 0.9202 92.02%
CYP3A4 substrate + 0.5808 58.08%
CYP2C9 substrate + 0.5963 59.63%
CYP2D6 substrate - 0.8662 86.62%
CYP3A4 inhibition - 0.8579 85.79%
CYP2C9 inhibition - 0.8598 85.98%
CYP2C19 inhibition - 0.9070 90.70%
CYP2D6 inhibition - 0.9532 95.32%
CYP1A2 inhibition - 0.7637 76.37%
CYP2C8 inhibition - 0.7553 75.53%
CYP inhibitory promiscuity - 0.9936 99.36%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.7640 76.40%
Eye corrosion - 0.9713 97.13%
Eye irritation - 0.8774 87.74%
Skin irritation - 0.5995 59.95%
Skin corrosion - 0.8676 86.76%
Ames mutagenesis - 0.7900 79.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6180 61.80%
Micronuclear - 0.7900 79.00%
Hepatotoxicity - 0.5658 56.58%
skin sensitisation - 0.7402 74.02%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.5667 56.67%
Mitochondrial toxicity + 0.6000 60.00%
Nephrotoxicity + 0.5955 59.55%
Acute Oral Toxicity (c) III 0.6378 63.78%
Estrogen receptor binding + 0.5690 56.90%
Androgen receptor binding + 0.6535 65.35%
Thyroid receptor binding - 0.6892 68.92%
Glucocorticoid receptor binding - 0.5907 59.07%
Aromatase binding - 0.7270 72.70%
PPAR gamma - 0.6942 69.42%
Honey bee toxicity - 0.9239 92.39%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.5300 53.00%
Fish aquatic toxicity + 0.9130 91.30%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 97.63% 83.82%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.25% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.23% 96.09%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 87.44% 99.23%
CHEMBL2581 P07339 Cathepsin D 85.78% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.18% 95.56%
CHEMBL1994 P08235 Mineralocorticoid receptor 83.96% 100.00%
CHEMBL221 P23219 Cyclooxygenase-1 83.35% 90.17%
CHEMBL1806 P11388 DNA topoisomerase II alpha 80.62% 89.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.60% 97.09%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Valeriana officinalis

Cross-Links

Top
PubChem 53363115
LOTUS LTS0200637
wikiData Q104911335